Genome-scale drop-out screens to identify cancer cell vulnerabilities in AML. (2019)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.gde.2019.04.004
PubMed Identifier: 31063922
Publication URI: http://europepmc.org/abstract/MED/31063922
Type: Journal Article/Review
Volume: 54
Parent Publication: Current opinion in genetics & development
ISSN: 0959-437X